MediKarma is the “Intel Inside” of the healthcare economy. Payers and platforms can now license specific AI Agents – longevity, prevention and chronic disease focused – along with the industry’s only universal EMR data ingestion engine.
SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ — MediKarma today announced a defining strategic shift with the launch of its Agentic AI Licensing Program, making it the first company in the healthcare industry to license out fully autonomous AI agents for wellness, disease management and enterprise data operations.
This move transitions MediKarma from a traditional product company into the fundamental infrastructure layer of modern healthcare. Much like computer manufacturers rely on a central processor to power their hardware, health plans, health systems, digital health companies and software platforms can now license MediKarma’s “AI Agents” to power their member experience. Licensing options include:
1. Jack AI: The Universal Enterprise Engine
At the core of the licensing model is Jack AI, a comprehensive enterprise intelligence stack designed to solve the industry’s data fragmentation problem. Partners can now license the following modular utilities:
2. Jill AI: Validated Engagement Agents on Demand
Powering the patient experience is Jill AI, a suite of autonomous engagement agents designed to solve the industry’s adherence and retention problem. Partners can now license the following validated personalities to manage distinct patient populations:
Quote from Kris Narayan, CEO of MediKarma:
“We are not building another app. We are building the brains that will power the entire industry and make life easier for patients. This is an ‘Intel Inside’ moment for healthcare. Right now, we are the only company that can bring in EMR data from anywhere – literally anywhere – and instantly make sense of it. By licensing our Agentic AI, we are giving health plans the ability to deploy validated, disease-specific experts like Diabetes Jill or Oncology Jill directly to their members. We are the first and only company doing this, and we are opening our doors to partners who want to stop guessing and start solving.”
Delivering Measurable ROI
The platform is designed to deliver immediate financial impact for partners:
About MediKarma
MediKarma is the industry leader in Agentic AI for healthcare. We are the first company to license autonomous AI agents that bridge the gap between universal data access and personalized care. By empowering partners with the ability to fetch data from any EMR and deploy validated AI agents, MediKarma serves as the operating system for the next generation of digital health.
Availability
The MediKarma Agentic AI Licensing Program, including SDKs for Jack AI utilities and the Jill AI suite, is available immediately. Enterprise partners can contact the commercial team to begin integration today.
For media inquiries, interviews, or partnership details, please contact:
Nataliya Howard
407461@email4pr.com
925.628.7424
www.medikarma.com
SOURCE MediKarma Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…
PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…
BELFAST, Northern Ireland , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…